Prospective Multicenter Study of Myocardial Recovery Using Left Ventricular Assist Devices (RESTAGE-HF [Remission from Stage D Heart Failure])
Emma J. Birks(Lung Institute), J. Eduardo Rame(Thomas Jefferson University Hospital), Chris Cunningham(John Radcliffe Hospital), Jaimin R. Trivedi(University of Louisville), Craig H. Selzman(University of Utah), Randall C. Starling(Cleveland Clinic), Stavros G. Drakos(University of Utah), Simon Maybaum(Northwell Health), Josef Stehlik(Intermountain Medical Center), Snehal R. Patel(Montefiore Medical Center), Brian D. Lowes(University of Nebraska Medical Center), Daniel J. Goldstein(Montefiore Medical Center), David J. Farrar(JTEC Corporation (Japan)), John Um(University of Nebraska Medical Center), Kenneth B. Margulies(Temple University), P. Alturi(University of the Sciences), Mark S. Slaughter(University of Louisville)
Cited by 218
Related Papers
The Role of Endomyocardial Biopsy in the Management of Cardiovascular Disease
|Circulation|2007|1k
Clinical management of continuous-flow left ventricular assist devices in advanced heart failure
|The Journal of Heart and Lung Transplantation|2010|876
Targeting cardiac fibrosis with engineered T cells
|Nature|2019|799
Pulmonary-Vein Isolation for Atrial Fibrillation in Patients with Heart Failure
|New England Journal of Medicine|2008|763
Intrapericardial Left Ventricular Assist Device for Advanced Heart Failure
|New England Journal of Medicine|2017|757